Antibiotic Resistance in Bacteria
This cluster of papers focuses on the global challenge of antibiotic resistance in bacteria, particularly the emergence and spread of multidrug-resistant bacteria, the role of ESKAPE pathogens, the mechanisms of carbapenemases and plasmid-mediated resistance, the impact of efflux pumps, and the prevalence of extended-spectrum ß-lactamases. It also covers the epidemiology and molecular biology of specific resistant bacteria such as Acinetobacter baumannii.
Papers listed on taxonomy pages are the top few works per node from the OpenAlex snapshot. That list is not exhaustive and is not an endorsement. The topic map and the journal registry remain separate: there is still no authoritative topic-to-venue or topic-to-organization edge. Search is a lexical lookup, not a claim that a venue publishes a topic.
Most cited
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- Origins and Evolution of Antibiotic Resistance
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- Identification of acquired antimicrobial resistance genes
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
Most recent
- Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms.
- Antibiotic Treatment of Severe Infections with Multiresistant Bacteria.
- A fitness advantage from the pLVPK plasmid fuels the global spread of a carbapenem-resistant hypervirulent Klebsiella pneumoniae high-risk clone: ST11-KL64
- Combinatorial action of regulatory systems generates colistin heteroresistance
- Population genomics, resistome and plasmidome of invasive Klebsiella pneumoniae isolates in adults hospitalised in Johannesburg, South Africa
- Cefepime versus piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa pneumonia